Veracyte (VCYT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Puneet Souda ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

A doctor at the centre of a review of the treatment of more than 200 patients with lung disease is being investigated by the ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Columnist Sam Kirton encourages the IPF community to get a jump on legislative advocacy before the new congressional term begins.

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Westlake Village-based MannKind saw rising revenue and gave a positive update to its orphan lung pipeline when it announced its earnings for the third quarter of 2024. MannKind, a biotechnology ...

More than 200 patients have had their lung disease treatment reviewed following concerns their care at a Surrey hospital did not meet best practice guidance, a board report said. A review by the Royal ...

NuvoAir Medical, a national leader in cardiopulmonary services will open an outpatient pulmonary clinic in Prescott, in order to keep outpatient pulmonary care local to Prescott-area residents.

Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at ...

Interested parties may access the live audio webcast for each conference via the Investors section of the Surrozen website at https://investors.surrozen.com/events-presentations/events-calendar. A ...